AVGO
69
20
DUK
64
2
BAX
30
-3
AIV
71
9
PLD
51
-5
PDCO
54
-4
BWA
45
-4
KEY
51
-3
FMC
40
4
LMT
47
7
SWKS
38
-2
EIX
69
3
HBI
62
4
HSIC
50
-3
RCL
76
2
SO
66
2
UAL
56
2
PPG
61
-5
SJM
38
-3
MSI
72
2
AVGO
69
20
DUK
64
2
BAX
30
-3
AIV
71
9
PLD
51
-5
PDCO
54
-4
BWA
45
-4
KEY
51
-3
FMC
40
4
LMT
47
7
SWKS
38
-2
EIX
69
3
HBI
62
4
HSIC
50
-3
RCL
76
2
SO
66
2
UAL
56
2
PPG
61
-5
SJM
38
-3
MSI
72
2
Financhill
Back

BMO Equal Weight Banks ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
68

ZEB.TO
BMO Equal Weight Banks ETF

Last Price:
40.55
Seasonality Move:
2.27%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
68
BMO Equal Weight Banks ETF (ZEB.TO) is a Buy

Is BMO Equal Weight Banks ETF a Buy, Sell or Hold?

  • The current BMO Equal Weight Banks ETF [ZEB.TO] share price is $40.55. The Score for ZEB.TO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • ZEB.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ZEB.TO Stock Price Chart

What is BMO Equal Weight Banks ETF's stock price today?

  • The BMO Equal Weight Banks ETF share price today is $40.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZEB.TO is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

ZEB.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.91 Buy
Relative Strength Index (14 RSI): 84.11 Buy
Chaikin Money Flow: 1093001 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.52 - 39.82) Buy
Bollinger Bands (100): (35.09 - 38.03) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

ZEB.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.1 Buy
20-day SMA: 39.03 Buy
50-day SMA: 37.51 Buy
200-day SMA: 35.88 Buy
8-day EMA: 40.04 Buy
20-day EMA: 39.16 Buy
50-day EMA: 37.89 Buy
200-day EMA: 36 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

BMO Equal Weight Banks ETF Earnings Growth & ZEB.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

BMO Equal Weight Banks ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):